SafeStitch Medical®, Inc. Renames the Product AMID™ Hernia Fixation Device
29 Mayo 2012 - 3:00PM
Business Wire
SafeStitch Medical®, Inc. (OTCBB: SFES), is pleased to announce
that it has officially changed the name of the AMID Stapler® to
AMID™ Hernia Fixation Device to better describe the functionalities
of the device.
Dr. Parviz Amid, inventor of the AMID
Hernia Fixation Device, Clinical Professor of Surgery at UCLA,
cofounder of the Lichtenstein Hernia Institute in 1986, and
Executive Director of Lichtenstein Amid Hernia Clinic at UCLA
(Photo: Business Wire)
“We believe the distinct features of the AMID Hernia Fixation
Device offer improved functionality, including the unique 45 degree
angle head, mesh manipulators and staple counter when compared to a
standard medical device stapler. We are excited to offer this
easy-to-use tool to health care professionals,” said Jeffrey
Spragens, President and CEO of SafeStitch Medical.
The AMID Hernia Fixation Device was created to offer an
innovative alternative to manual suturing for inguinal hernia
repair using the Lichtenstein method. The design fixates mesh by
delivering staples in a parallel plane to the femoral vessels,
which may help avoid vascular injury. The AMID Hernia Fixation
Device allows for mesh manipulation, mesh fixation and skin
closure.
Dr. Parviz Amid, inventor of the AMID Hernia Fixation Device,
Clinical Professor of Surgery at UCLA, cofounder of the
Lichtenstein Hernia Institute in 1986, and Executive Director of
Lichtenstein Amid Hernia Clinic at UCLA, stated, “The unique
features of mesh manipulators and angled head help ease the open
hernia repair procedure.”
The AMID Hernia Fixation Device is sold nationwide.
About SafeStitch Medical, Inc.
Miami, Florida-based SafeStitch Medical, Inc. is a publicly
traded medical device company founded by Charles J. Filipi M.D. and
Jeffrey G. Spragens, along with Creighton University, in 2005, to
develop a prototype for a minimally invasive obesity procedure. In
the summer of 2006, Phillip Frost M.D., Chairman and CEO of OPKO
Health, Inc. and Jane Hsiao Ph.D., Vice-Chairman and Chief
Technical Officer of OPKO Health, Inc. became partners in
SafeStitch Medical, Inc. and expanded SafeStitch’s mission to
develop and market the best in class disposable medical devices to
advance minimally invasive surgery for hernia repair, treatment of
obesity and other gastroesophageal disorders. Information about the
Company may be found on its website
at: www.safestitch.com.
This press release contains "forward-looking statements," as
that term is defined under the Private Securities Litigation Reform
Act of 1995 (PSLRA), which statements may be identified by words
such as "expects," "plans," "projects," "will," "may,"
"anticipate," "believes," "should," "intends," "estimates," and
other words of similar meaning, including statements regarding our
product development and commercialization efforts, and our ability
to significantly improve clinical outcomes in patients, as well as
other non-historical statements about our expectations, beliefs or
intentions regarding our business, technologies and products,
financial condition, strategies or prospects. Many factors,
including those described herein and in our filings with the
Securities and Exchange Commission, could cause our actual
activities or results to differ materially from the activities and
results anticipated in forward-looking statements. These factors
include: whether the AMID Hernia Fixation Device offers improved
functionality when compared to a standard medical device stapler;
whether the AMID Hernia Fixation Device may help avoid vascular
injury; and whether unique features of mesh manipulators and angled
head help ease the open hernia repair procedure. The
forward-looking statements contained in this press release speak
only as of the date the statements were made, and we do not
undertake any obligation to update forward-looking statements,
except as required under applicable law. We intend that all
forward-looking statements be subject to the safe-harbor provisions
of the PSLRA.
Photos/Multimedia Gallery Available:
http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50291302&lang=en
TransEnterix (AMEX:TRXC)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
TransEnterix (AMEX:TRXC)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024